The AHA today urged President-elect Biden to provide strong federal leadership on the COVID-19 vaccine distribution and administration process, and it pledged to work with the incoming administration in expediting the administration of vaccines throughout the nation.

“This effort must be large and multifaceted, and it will require exceptional leadership and coordination to ensure none of the vaccine is wasted,” AHA said. “The most challenging task will be the work to keep the manufacturers, distributors, state and local officials, hospitals, pharmacies, other providers, schedulers, planners, site coordinators, data collectors, and others working as a team. We strongly believe the most important role for your administration will be to act as the quarterback for this massive undertaking.”

Read AHA’s letter for more detailed comments.

Related News Articles

Headline
The Centers for Disease Control and Prevention Dec. 11 released a report that found last year’s version of the COVID-19 vaccine was 76% effective in preventing…
Headline
The AHA provided recommendations to the Food and Drug Administration Dec. 1 in response to a request for information on the measurement and evaluation of…
Headline
The Food and Drug Administration has identified a Class I recall of Baxter Life2000 Ventilation Systems due to a cybersecurity issue discovered through…
Headline
Flu cases are growing or likely growing in 39 states, according to the latest Centers for Disease Control and Prevention data from Nov. 11. COVID-19…
Headline
The Food and Drug Administration yesterday published an announcement from Otsuka ICU Medical saying that the company issued a voluntary recall for a mislabeled…
Headline
A study published Oct. 30 by the American Heart Association found that people have an elevated risk of heart attack and stroke following flu and COVID-19…